VIDEO: Tranexamic acid may be safe for patients with cancer who undergo hip replacement
Click Here to Manage Email Alerts
LAS VEGAS — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Nicola Fabbri, MD, discussed the use of tranexamic acid for patients with metastatic cancer who undergo total hip arthroplasty or hemiarthroplasty.
“Historically, the use of tranexamic acid has been seen as potentially not safe in the cancer population because of the increased risk for thromboembolic disease,” Fabbri said. “[Tranexamic acid] in this study has been safe and effective for reducing perioperative bleeding and transfusion requirements without increasing the risk of thromboembolic disease when administered in adult patients older than 18 [years] at the dose of 1 gram every 3 hours,” he added.
Collapse
Fabbri N, et al. Paper 400. Presented at: American Academy of Orthopaedic Surgeons Annual Meeting; March 7-11, 2023; Las Vegas.
Click Here to Manage Email Alerts